PLEKHA4 and astrocytoma (excluding glioblastoma): Meanwhile, PLEKHA4 expression was significantly different among subgroups stratified by histological type (P<0.001) and primary therapy outcome (P<0.001), and patients of astrocytoma (A) or progressive disease (PD) types usually have higher PLEKHA4 expression levels.